After three years of follow-up, the study showed that when combined with cataract surgery, Glaukos iStent inject Trabeculat Micro-Bypass System achieved a 37% reduction in IOP.
iStent inject works to help control the increased pressure in the eye associated with glaucoma by creating openings between the front part of the eye and its natural drainage passageway to increase the flow of fluid. This leads to improvement of the eye’s natural outflow to safely lower intraocular pressure and work continuously to improve the natural flow of fluid in the eyes
Visit Glaukos for more product details.
Full article available here.